A new weight loss pill—known as orforglipron and developed by Eli Lilly—is generating significant attention as a potential alternative to injectable treatments. But when will it actually be available in the UK?
What Is Orforglipron?
Orforglipron is an oral GLP-1 receptor agonist, designed to work in a similar way to injectable medications like Mounjaro and Wegovy. These medications help regulate appetite, slow gastric emptying, and improve blood sugar control.
In clinical trials, patients taking orforglipron achieved approximately 12–15% average weight loss over 36–72 weeks, placing it within the same category as established GLP-1 treatments.
UK Approval Process
Before being made available in the UK, orforglipron must be approved by the Medicines and Healthcare products Regulatory Agency (MHRA).
Even after MHRA approval, it must also be assessed by NICE (National Institute for Health and Care Excellence), which determines whether it can be prescribed on the NHS.
Expected Timeline
Based on previous drug launches:
- US approval: 2026
- UK MHRA review: typically 6–12+ months after submission
- NICE approval and NHS rollout: additional 6–18 months
This suggests UK availability is most likely late 2026 to 2027 (private), with NHS access potentially later.
Why This Matters
More than 64% of UK adults are overweight or obese, and demand for effective weight loss treatments is rapidly increasing. A pill format could significantly expand access—but availability will take time.
What Can You Do Right Now?
While the pill is not yet available, proven and regulated treatments are already accessible in the UK.
At www.pprx.co.uk, we offer access to clinically approved medications including Mounjaro and Wegovy, following a simple online consultation.
These treatments have demonstrated:
- Up to 20%+ body weight reduction (Mounjaro)
- Around 15% average weight loss (Wegovy)
Start Your Journey Today
Rather than waiting for future treatments, you can begin your weight loss journey now.
Visit www.pprx.co.uk and fill out your consultation today to see if you’re eligible for Mounjaro or Wegovy.
At PPRX UK, we provide:
- Genuine Mounjaro pens, sourced directly from the manufacturer (Eli Lilly)
- Dispensing via a GPhC-registered UK pharmacy
- Professional consultations with UK pharmacists
- Ongoing support, dosage guidance, and repeat supply options
Whether you're just starting or switching from Ozempic or Wegovy, we’re here to help.
📞 Get in Touch
Visit www.pprx.co.uk or contact us directly to begin your online consultation.
We offer fast, discreet UK-wide delivery and exceptional support throughout your journey.
Mounjaro is a prescription-only medicine. This article is for informational purposes only and does not replace medical advice. Always consult a qualified healthcare provider before starting treatment. nhs
This article is general information, not medical advice, and doesn't replace a consultation. Whether a treatment is right for you — and at what dose — is a decision made with a PPRX clinician who reviews your history.